Dipeptidyl aminopeptidases (DPAPs) are druggable cysteine proteases that cleave dipeptides from the N-terminus of proteins and oligopeptides. Plasmodium DPAPs have been shown to be important for the asexual replication of the malaria parasite and are therefore potential antimalarial targets. DPAP1 seems to be important for parasite growth within infected red blood cells, and DPAP3 plays a critical role in the invasion of erythrocytes by the malaria parasite. An inhibitor able to block both of these proteases will target the parasite at different developmental stages thus making the emergence of drug resistance more difficult.Understanding the substrate specificity of these proteases is important to understand their molecular functions and to help develop potent and selective inhibitors. In this study, we used peptide-based libraries of substrates and inhibitors to determine the specificity of DPAP3 and compared it to that of DPAP1 and human cathepsin C (mammalian DPAP homologue). We then used the structure activity relationships information from these screens to develop optimal DPAP3 fluorogenic substrates as well as highly specific DPAP1 and DPAP3 inhibitors.Interestingly, while the substrate specificity of a protease is often used to develop potent inhibitors, in this study we show that equally potent and highly specific inhibitors can be developed based on the structure of poor substrates. Overall, this study illustrates that focusing the development of peptidic inhibitors solely on the substrate specificity of a protease might overlook important structural features that can be exploited to developed highly potent and selective compounds.not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/246124 doi: bioRxiv preprint first posted online Jan. 11, 2018; 3 Malaria is a devastating infectious parasitic disease causing close to half a million deaths every year 1 . Over the last 15 years the world has seen a very significant drop in malaria incidence, mainly due to the global distribution of insecticide-impregnated bed nets and the use of artemisinin-based combination therapies as the standard of care for uncomplicated malaria 2 .However, malaria remains a major global health burden with half of the world population at risk and around 200 million clinical cases per year. Unfortunately, mosquitoes are becoming increasingly resistance to insecticides 3 and artemisinin resistance is on the rise 4 , thus making the identification of antimalarial targets and the development of drugs with novel mechanisms of action extremely urgent 5 .Malaria is caused by parasites of the Plasmodium genus and is transmitted by Anopheles mosquitoes during a blood meal. Upon infection, malaria parasites first establish an asymptomatic infection in the liver before reaching the blood stream where they replicate asexually through multiple rounds of red blood cell (RBC) invasion, intracellular growth and divis...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.